BRCA1 and breast cancer: Of note, one additional White participant with a BRCA1 VUS was clinically reclassified as pathogenic despite being persistently categorized as a VUS by the participant’s testing laboratory due to the participant’s mother having the same VUS reclassification to pathogenic by another laboratory (in the context of a strong family history of breast cancer).